It may present the potential for introducing GRK2 expression modulation as an innovative treatment strategy to restore compromised atrial myocyte function and prevent AF attacks for patients with chronic sleep disturbances complicated by heart failure and AF. The gene discussed is GRK2; the disease is heart failure.